Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)
CAPS Rating:
A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.
RSS Headlines
Fool UK
Recs
There are currently 4000 IDIX shares in my "fund" with break-even of around 5.92 USD.
http://caps.fool.com/Blogs/fund-trades/671856.
now 2000 shares in the fund with break-even of around 0.10 USD.
http://caps.fool.com/Blogs/fund-trades/716433.